Investor

Software for the life science

In recent years, biocomputing or bioinformatics has become a valuable tool for researchers in companies, universities and other organizations in their dealings with complex biological systems. In the biotechnology industry for example, bioinformatics is now routinely employed during the early stages of the drug design process, where it is most commonly used to discover possible targets for pharmaceutical intervention. In this sector, the impact of bioinformatics is expected to shift towards the analysis of proteins and their interactions with other molecules in the cell.

Dedicated software for the life science, however, can and will have a much greater impact. Ongoing developments in biomedicine, biotechnology, biology, chemistry and so forth increases the demand for highly sophisticated software. Among other, one can think of advanced analysis software and simulation tools for the analysis and prediction of particular binding processes at interfaces such as biochips. Life science companies will outsource the tasks of developing such very advanced software tools to IT companies that also have a strong background in the life science and truely understand the concepts of the field. Triacle Biocomputing is exactly such a BioIT company.